TIL Immunotherapy Treatment for Metastatic Melanoma in Israel
Tumor-infiltrating lymphocytes (TIL) immunotherapy is a modern treatment for patients with advanced stage metastatic melanoma who have experienced little or no benefit from conventional therapies. About 50% of these patients show improvement with TIL and approximately 25% of patients are cured of their melanoma.
TIL is offered at only a few medical institutes worldwide, and we are proud to provide this innovative treatment for patients from the UAE at the Ella Lemelbaum Institute for Immuno-Oncology at Sheba Medical Center in Israel. Our campus is located closer to the UAE than Europe and the United States, and the cost of treatment is lower.
What Is Til Immunotherapy
TILs, or tumor-infiltrating lymphocytes, are special immune system cells (T cells) that are naturally present inside some tumors.
TIL immunotherapy consists of collecting TILs from a tumor during a biopsy, or surgical resection, and growing them to very large numbers in a laboratory with interleukin-2 (IL-2), a protein that promotes rapid TIL growth. Once successfully grown to billions in number, the TILs are infused back into the patient, where they actively attack cancer cells.
Your immune system is thus able to produce a stronger, more focused response against the tumor cells.
What Conditions Do We Treat with TIL Immunotherapy at Sheba?
At present, TIL immunotherapy is offered to patients from the UAE who have advanced metastatic melanoma that has not responded to conventional cancer treatments.
Why Choose Sheba for TIL Immunotherapy
TIL is available in only a very few countries. Sheba Medical Center in Israel is a great choice for your TIL Immunotherapy treatment destination for several reasons:
On the Frontline
We have been actively engaged with TIL research, collaborating closely with the National Institutes of Health (NIH) in the United States.
The fees at Sheba are transparent and affordable, with no hidden costs
Experienced Medical Experts
Our staff features many of the world’s leading, highly experienced TIL specialists.
We have full accreditation from the Joint Commission International (JCI), the foremost healthcare center accreditation authority
Top Notch Facility
You will receive treatment at the Ella Lemelbaum Institute for Immuno-Oncology, a modern; facility devoted entirely to cancer immunotherapy research and treatment.
You will have access not only to TIL treatments, but to a broad range of specialized cancer therapies
A personal coordinator from our Global Patient Services team will assist you throughout your entire time at Sheba, including helping you with travel arrangements, translation, family accommodations and many other needs
Why Come to Sheba from the UAE?
Presently, the UAE sends many complex patient cases to other countries, and now, Sheba offers a treatment option for metastatic melanoma that is closer than Europe and less expensive than the United States. Many members of the medical staff also speak Arabic, creating a comfortable atmosphere – like a home away from home.
TIL immunotherapy in Israel provides patients from the UAE with custom designed advanced treatment administered by world-renowned cancer specialists. Not only is Sheba the largest, most comprehensive hospital in the Middle East, but for the past two years it was ranked by Newsweek as one of the top 10 hospitals in the world. As a leading international force in medicine and biotechnological innovation, Sheba offers many treatments and technologies that are unavailable elsewhere. Presidents, VIPs and top-level executives regularly choose Sheba for medical treatment.
Joining forces to advance patient care:
Sheba Medical Center and APEX National Investment, based in Abu Dhabi, recently signed a memorandum of agreement, laying the groundwork for medical tourism, medical training and digital healthcare innovation. To encourage startups, Sheba and APEX will set up a collaborative healthcare hub for the UAE modeled after the ARC Innovation Center on Sheba’s campus in Israel.
“We think choosing TIL at Sheba was undoubtedly the best decision. That is what saved my husband.”
Mike and Michaela Herstig, married for 40 years and living in Bangkok, were terrified by Mike’s diagnosis of stage 4 metastatic melanoma. Unwilling to give up, Michaela researched the best available treatment options, which led her to Sheba Medical Center in Israel. Innovative TIL immunotherapy was recommended as a highly effective treatment, and Mike and Michaela decided to give it a try.
Jacob Schachter, MD, PhD
Director Emeritus, the Ella Lemelbaum Institute for Immuno-Oncology Deputy Director of the Oncology Division, The Sheba Medical Center
Prof. Schachter is one of the most prominent oncologists practicing in the field of melanoma in Israel. In 2004, he founded the Ella Institute, which offers innovative treatments for melanoma patients, including innovative TIL immunotherapy, available today only at a few cancer centers worldwide. Prof. Schachter is involved in planning and implementing many researches in melanoma treatment, and he has published more than 50 scientific papers on melanoma and tumor immunologyRead More
Holistic healing at Sheba
When providing TIL immunotherapy in Israel, we consider all aspects of each patient’s overall wellness and quality of life, including physical, emotional, and social needs. We aim to create the most customized, comfortable and efficient experience possible, with all-inclusive services, such as psychology, social services, beneficial complementary medicine, and palliative care offered under one roof on our vast campus. Every patient is also assigned a personal medical coordinator from Global patient services, who provides assistance throughout every step of the treatment.
Sheba Medical Center Transforming Healthcare and Biomedical Innovation
Request a consultation
Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.
We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.
Request a consultation and a Sheba Case Manager will contact you shortly: